Adenofection: A Method for Studying the Role of Molecular Chaperones in Cellular Morphodynamics by Depletion-Rescue Experiments

Summary

We describe a method for depletion-rescue experiments that preserves cellular integrity and protein homeostasis. Adenofection enables functional analyses of proteins within biological processes that rely on finely tuned actin-based dynamics, such as mitotic cell division and myogenesis, at the single-cell level.

Abstract

Cellular processes such as mitosis and cell differentiation are governed by changes in cell shape that largely rely on proper remodeling of the cell cytoskeletal structures. This involves the assembly-disassembly of higher-order macromolecular structures at a given time and location, a process that is particularly sensitive to perturbations caused by overexpression of proteins. Methods that can preserve protein homeostasis and maintain near-to-normal cellular morphology are highly desirable to determine the functional contribution of a protein of interest in a wide range of cellular processes. Transient depletion-rescue experiments based on RNA interference are powerful approaches to analyze protein functions and structural requirements. However, reintroduction of the target protein with minimum deviation from its physiological level is a real challenge. Here we describe a method termed adenofection that was developed to study the role of molecular chaperones and partners in the normal operation of dividing cells and the relationship with actin remodeling. HeLa cells were depleted of BAG3 with siRNA duplexes targeting the 3'UTR region. GFP-tagged BAG3 proteins were reintroduced simultaneously into >75% of the cells using recombinant adenoviruses coupled to transfection reagents. Adenofection enabled to express BAG3-GFP proteins at near physiological levels in HeLa cells depleted of BAG3, in the absence of a stress response. No effect was observed on the levels of endogenous Heat Shock Protein chaperones, the main stress-inducible regulators of protein homeostasis. Furthermore, by adding baculoviruses driving the expression of fluorescent markers at the time of cell transduction-transfection, we could dissect mitotic cell dynamics by time-lapse microscopic analyses with minimum perturbation of normal mitotic progression. Adenofection is applicable also to hard-to-infect mouse cells, and suitable for functional analyses of myoblast differentiation into myotubes. Thus adenofection provides a versatile method to perform structure-function analyses of proteins involved in sensitive biological processes that rely on higher-order cytoskeletal dynamics.

Introduction

Functional inactivation of gene expression in mammalian cells is the gold standard to dissect protein functions. Newly developed technologies of genome editing based on the use of site-specific nucleases such as Zinc-finger nucleases and clustered regularly interspaced short palindromic repeats (CRISPR)/CAS9 now allow the generation of cell lines with targeted gene deletion and mutation^1,2. These novel approaches should revolutionize the way we are studying protein function and our understanding of the genetics of human diseases. In some instances, however, long-term or complete gene knockout is not desirable and may provoke secondary cell compensation mechanisms. The generation of genetically modified cell lines can also be limiting when dealing with primary cell cultures with limited proliferation capacity, or when screening of a large set of mutations in various cell types is sought. This is often required for determining the dependence of a cell biological process on structural requirements of a protein. To that end, reversible knockdown by RNA interference that enables transient depletion-rescue experiments in various cellular backgrounds still remains a simple and powerful approach to perform structure-function analyses of a protein of interest³. However, a major drawback to this approach is the difficulty to achieve efficient silencing and to reintroduce the protein of interest or its variants at near physiological levels in a majority of the cell population. This is crucial to enable comprehensive studies that attempt to correlate functional effects seen at the level of single cells (hypomorphic phenotype) with those seen in cell population-based assays, for instance on protein-protein interactions.

Using classic transfection methods, one can hardly achieve homogenous and low expression of exogenous proteins in a large population of cells. Transduction of cells with recombinant viruses like adenoviruses often enables more normalized expression of exogenous proteins. Yet, adenovirus uptake is limited by the CAR receptor, which is absent in non-human cells or only weakly expressed in some human cell types. Furthermore, the cellular entry of adenoviruses activates signaling pathways that regulate cell shape and adhesion^4-6. This is obviously not desirable when studying regulatory mechanisms of cell morphodynamics. We were facing this problematic when we undertook functional analyses of a chaperone complex, BAG3-HSPB8, in cell division and actin dynamics. Pioneering work had described a role for this chaperone complex in protein quality control and autophagy during stress^7,8. Most of these studies, however, relied on protein overexpression, assuming that the chaperones are normally upregulated during stress. This has left open the question of whether BAG3, in complex with HSPB8, can contribute to the normal operation of dividing cells expressing these chaperones like many cancer cell types⁹. In particular, whether the chaperone complex contributes to the remodeling of actin-based structures that control mitotic progression was of great interest, given the emerging connections between HSPB chaperones and cytoskeletal dynamics¹⁰. To address this issue, we were seeking to develop an efficient method for depletion-rescue experiments that would not interfere with mitotic progression or cellular morphology, and which would preserve protein homeostasis to avoid secondary perturbation of the dynamics of macromolecular complexes regulating cell-shape changes. Thus ideally, depletion-add-back of the gene of interest should be performed simultaneously.

The use of complexes of adenovirus with a cationic polymer or lipids has been described to promote gene transfer in vitro and in vivo^11,12. For instance, calcium phosphate (CaPi) appears to form a precipitate with adenovirus that enhance virus binding-entry via a CAR-independent pathway¹³. Indeed, we found that combining adenovirus-based cell transduction and transfection with cationic compounds could enhance the efficiency of the depletion-rescue experiments. This allowed us to lower the amounts of virus by 3- to 20-fold, depending on the cell line and the gene of interest, and benefit from a wider window in order to adjust the expression of exogenous proteins at near endogenous levels in the majority of a cell population of interest with minimum impact on cellular morphology. Under such conditions, we could also achieve high efficiency knockdown of endogenous protein expression (>75%). We hereby describe the method step by step and provide evidence that protein homeostasis is not significantly perturbed as assessed by the unchanged levels of stress-induced chaperones of the Heat Shock Protein family, making the method suitable for functional analyses of the physiological role of molecular chaperones by time-lapse video microscopy. The protocol is amenable to cell synchronization procedures and to the use of commercially available baculoviruses for co-expression of low levels of fluorescent markers, with minimum interference with normal actin-based and spindle dynamics during mitotic progression. We further show the versatility of the method, which is applicable to "hard to transduce" mouse C2C12 cells, with no significant impact on myoblast differentiation into myotubes in vitro.

Protocol

1. Preparation of Medium and Solutions (all sterile filtered)

1. C2C12 mouse muscle cells (differentiation studies)
   1. Prepare 500 ml of Growth Medium for C2C12 cell culture maintenance: DMEM High Glucose supplemented with 10 % FBS and 2mM L-Glutamine.
   2. Prepare 100 ml Differentiation Medium (DM) for C2C12 differentiation: DMEM High Glucose supplemented with 2% Horse Serum.
2. HeLa cells (studies in mitotic cells)
   1. Prepare 500 ml αMEM for HeLa RFP-H2B cell culture maintenance and experiments: αMEM supplemented with 10% FBS and 2 mM L-Glutamine (αMEM^10%).
   2. Prepare 500 ml αMEM-minus (without deoxyribonucleosides/ribonucleosides) for HeLa RFP-H2B cell synchronization: αMEM-minus supplemented with 10% FBS and 2 mM L-Glutamine (αMEM-minus^10%).
   3. Prepare 20 ml αMEM without Phenol Red for HeLa-RFP-H2B live cell acquisition: αMEM without Phenol Red supplemented with 10% FBS and 2 mM L-Glutamine.
   4. Prepare 100 mM thymidine: dissolve 24.2 mg in 1 ml H₂O at 37 °C by vortexing. Filter sterilize and keep at 4 °C.
3. Common solutions
   1. Prepare 0.05% Trypsin/EDTA: 0.05% Trypsin, 0.625 mM EDTA in 1x phosphate buffered saline (PBS). Filter sterilize and store aliquots at -20 °C. Once thawed, keep aliquot at 4 °C.
   2. Prepare HBS2x: 280 mM NaCl, 50 mM HEPES, 1.5 mM Na₂HPO₄. Adjust pH exactly between 7.01-7.05 with 10 N NaOH. Filter sterile and keep at 4 °C.

2. Coating of Cell Culture Plates with Fibronectin and Plating of HeLa-RFP-H2B Cells

NOTE: Prior to the experiment, each manipulator should set up the optimal cell plating conditions to achieve a proper density of cells since variations may occur between each manipulator and each different cell line.

1. The day before the experiment, expand HeLa-RFP-H2B cells to make sure that they are within the exponential phase of growth on the day of plating. Make 2 successive 1/3 dilutions in 10 cm plates starting from an 80% confluent 1x10 cm plate.
   NOTE: Plan the number of plates for the experiment. Calculate each condition as duplicates, one for short-term live-cell imaging and one for protein extracts to determine the efficacy of knockdown and exogenous protein expression by Western blot analysis. Plan one additional plate to determine the cell number prior to virus transduction.
2. Prior to cell plating, coat glass bottom dishes with 10 μg/ml fibronectin. Add 1 ml of a 1:100 dilution of 1 mg/ml fibronectin (diluted in sterile 1x PBS) per 35 mm dish to well cover the whole surface and incubate for 1 hr at 37 °C, 5% CO₂.
3. During the incubation, pre-warm αMEM supplemented with 10% FBS (αMEM^10%) and 0.05% Trypsin/EDTA at 37 °C.
4. After 45 min of incubation, start preparing the cell solution. In the sterile hood, aspirate the medium from a 10 cm plate, rinse gently twice with 1.5 ml 0.05% Trypsin/EDTA, and leave 0.5 ml of Trypsin/EDTA at the last aspiration.
5. Incubate the cells for 2-3 min at 37 °C, 5% CO₂. By gently tapping the plate and observation under the microscope, verify that all cells have been detached. Add 10 ml of αMEM^10% and pipette gently several times to separate the cells. Count a 10 μl sample of the cell suspension using a haemocytometer.
6. Aspirate fibronectin solution from the glass bottom dishes. Do not allow fibronectin to dry out before cell plating.
7. Plate 1.5x10⁵ cells per 35 mm dish in 2 ml αMEM^10% and incubate at 37 °C, 5% CO₂. Verify after 30-45 min under the microscope that the cells are well separated, since they have the tendency to accumulate in the center of the plate.
8. If necessary, agitate the plates gently cross-wise to redistribute the cells. Plate one 35 mm plate additional to the number of conditions in order to count the cell number prior to virus transduction.
9. Grow cells until the next day to achieve a cell density of at least 50%. A cell density lower than 50% results in a significant decrease of virus transduction efficiency, increased variations of protein expression per cell, and increased cell toxicity.
   NOTE: Coating of glass dishes with fibronectin improves cell growth and morphology and promotes proper progression of cells through mitosis. It can generally be replaced by commercially available gelatin that is cheaper.

3. Adenovirus Transduction and Endogenous Protein Knockdown by siRNA Transfection in HeLa-RFP-H2B Cells Using CaPi Precipitates

Caution! Working with viruses requires special precautions and a proper disposal of all material that has been in contact with the virus.

Caution! In our hands, CaPi precipitates often have more undesirable effects, for instance on biological processes involving vesicle trafficking (e.g., autophagy). Accordingly it is recommended to use a cationic lipid transfection reagent (see below) and to wait at least 48 hr before the analyses.

NOTE: A control adenovirus carrying an unrelated gene (i.e., LacZ) or no gene is used to reach a minimal MOI in all Adenofections (10-20 pfu/cell) using the lowest amount of recombinant adenovirus carrying the gene of interest.

NOTE: This procedure has been shown to help normalizing expression per cell in a large cell population.

1. One day after cell plating, count the number of cells from the additional plated dish. Aspirate the medium and rinse once with 1 ml 0.05% Trypsin/EDTA. Add again 1 ml of 0.05% Trypsin/EDTA and incubate at 37 °C, 5% CO₂ until all cells have detached. Separate the cells well using a 1ml pipette and count the number of cells per ml using a haemocytometer.
2. Determine the quantity of virus needed to transduce cells at a multiplicity of infection (MOI) of 2 plaque-forming units (PFU) of the protein of interest (POI) per cell and 18 PFU per cell of an empty vector (e.g., LacZ) to have a total of 20 PFU per cell. At the same time transduce 4 PFU of each baculovirus (Actin and αTubulin, GFP and RFP-tagged respectively). Transduce the cells using the following adenofection protocol. Viruses were used as described in Fuchs et al. ¹⁴
3. Prepare in a sterile hood a 1.5 ml plastic tube for each condition and add 400 μl of warm αMEM-minus^10%.
4. Thaw an aliquot of the viruses slowly on ice and, if necessary, dilute the virus stock in order to pipet a volume greater than 1 μl to minimize pipetting errors.
5. Add the calculated virus quantity per condition to each 1.5 ml plastic tube containing 400 μl αMEM-minus^10% and mix gently by pipetting. Place the virus stock immediately back at -80 °C to keep its activity.
6. Aspirate the medium from the cells and gently pipette the virus mix drop-wise. Incubate the cells at 37 °C, 5% CO₂ and agitate the plates carefully under the sterile hood each 15 min for 1 hr to well cover the cells with the virus. Using a small amount of medium facilitates the contact of the virus with the cells.
7. After incubation, gently pipette 1.6 ml αMEM-minus^10% to each plate to obtain a total volume of 2 ml, start cell synchronization by adding 2 mM thymidine and incubate the cells for a further 2 hr at 37 °C, 5% CO₂.
8. Meanwhile, prepare the siRNA transfection mix following the CaPi transfection method (see Figure 1). If no siRNA is necessary, replace the amount of siRNA by sterile water to perform an empty transfection.
9. Calculate 200 μl mix for each condition, resulting in 400 μl per duplicate. The following example is given for a final siRNA concentration of 50 nM and has to be adapted for each protein of interest. In a 1.5 ml plastic tube, pipette 50 μl 1 M CaCl₂ and 11 μl 20 μM siRNA into 139 μl sterile H₂O and mix by vortexing. After a quick spin, add carefully drop-wise 200 μl HBS2x (280 mM NaCl, 50 mM HEPES, 1.5 mM Na₂HPO₄, pH 7.01-7.05).
   NOTE: The smaller the drops the smaller are the precipitates, resulting in better transfection efficiency. Gently mix three times by air injection using a 200 μl-pipette.
10. Incubate the mix for 30 min at RT. Add slowly drop-wise 200 μl of transfection mix to each plate and agitate cross-wise. Transfer the plates at 37 °C, 5% CO₂ for 16 hr.
11. The next day, rinse cells twice with 2 ml warm HEPES (6.7 mM KCl, 150 mM NaCl, 10 mM HEPES, pH 7.3) and add 2 ml αMEM-minus^10%. Do not proceed with more than four cell plates at a time since variations in the temperature affect the length of the cell cycle.
12. Visualize the infection efficiency under an inverted fluorescent microscope at a magnification of 20-40x (air) and acquire three representative images per condition in both fluorescent and transmission channels for documentation. Seven hours later, add 2 mM thymidine and incubate for a further 16 hr at 37 °C, 5% CO₂.
13. The following day, 48 hr after siRNA transfection and virus infection, rinse the cells twice with 2 ml warm phosphate buffer saline (PBS) and release for 7 hr in 2 ml αMEM^10% w/o Phenol Red for live cell imaging or with Phenol Red for protein extraction.
14. Harvest cells for each condition 48 hr post-transfection for preparation of protein extracts and Western blot analysis to determine the efficiency of knockdown and the expression of the endogenous protein¹⁵.
    NOTE: Use antibodies against the protein of interest as well as appropriate antibodies serving as loading controls. The efficiency of knockdown should be determined by loading decreasing amounts of control cell lysates (transfected with control siRNA), to provide a titration curve (i.e., 1, ½, ¼, ⅛).

4. Adenovirus Transduction and Endogenous Protein Knockdown by siRNA Transfection in HeLa Cells Using a Cationic Lipid Transfection Reagent

NOTE: Here we present a protocol that was adapted for experiments that do not involve cell synchronization and/or when siRNA transfection cannot be performed by the CaPi method, for instance to avoid undesirable toxic effects in some cell lines. This protocol also includes a cell replating step after adenofection in order to work at a suitable cell density. We have only tested the cationic lipid transfection reagent.

Caution! Working with viruses requires special precautions and a proper disposal of all material that has been in contact with the virus.

1. Plate 1.75 x 10⁵ cells per 35 mm dish in 2.5 ml αMEM^10% and incubate at 37 °C, 5% CO₂. Plate one 35 mm plate additional to the number of conditions in order to count the cell number prior to virus transduction.
2. Grow cells until the next day to achieve a cell density of at least 50%. A cell density of less than 50% results in a significant decrease of virus transduction efficiency, increased variations of protein expression per cell, and increased cell toxicity.
3. One day after cell plating, count the number of cells from the additional plated dish. Aspirate the medium and rinse once with 1 ml 0.05% Trypsin/EDTA. Add again 1 ml of 0.05% Trypsin/EDTA and incubate at 37 °C, 5% CO₂ until all cells have detached. Separate cells well using a 1 ml pipette and count the number of cells per ml.
4. Determine the quantity of virus needed to transduce a multiplicity of infection (MOI) of 20-40 plaque-forming units (PFU) of the protein of interest (POI) per cell and 0-20 PFU per cell of an empty vector (e.g., LacZ) to have a total of 40 PFU per cell.
5. Prepare in a sterile hood a 1.5 ml plastic tube for each condition and add 400 μl of warm αMEM^10%.
6. Thaw an aliquot of the viruses slowly on ice and, if necessary, dilute the virus stock in order to pipet a volume greater than 1 μl to minimize pipetting errors.
7. Add the calculated virus quantity per condition to each 1.5 ml plastic tube containing 400 μl αMEM^10% and mix gently by pipetting. Place the virus stock immediately back at -80 °C to keep its activity.
8. Aspirate the medium from the cells and gently pipette the virus mix drop-wise. Incubate the cells at 37 °C, 5% CO₂ and agitate the plates carefully under the sterile hood each 15 min for 1 hr to well cover the cells with the virus dilution. Using a small amount of medium facilitates the contact of the virus with the cells.
9. Meanwhile, prepare the siRNA transfection mix following the transfection method. If no siRNA is necessary, replace the amount of siRNA by medium without serum to perform an empty transfection.
   1. The following example is given for a final siRNA concentration of 50 nM and has to be adapted for each protein of interest. For each adenofection, prepare one 1.5 ml plastic tube containing 416 nM siRNA in 150 µl medium without serum (e.g., 6.25 µl 20 µM siRNA + 144 µl medium without serum) and one 1.5 ml plastic tube containing 6.25 µl cationic lipid transfection reagent + 144 µl medium without serum.
   2. Mix the content of each plastic tube by pipetting up and down several times with a 200 μl pipette. Combine the content of both tubes and mix by pipetting up and down several times with a 200 μl pipette. Incubate for 5 min at RT.
10. After incubation with the virus, gently pipette 1.8 ml αMEM^10% to each plate to obtain a total volume of 2.2 ml and immediately add slowly drop-wise the siRNA transfection mix to each plate and agitate cross-wise. Transfer the plates at 37 °C, 5% CO₂ for 24 hr.
11. The next day, re-plate the cells from each 35 mm plate into four new 35mm plates in 2.5 ml αMEM^10% each and incubate for an additional 24 hr at 37 °C, 5% CO₂.
12. The next day, 48 hr after siRNA transfection and virus infection, harvest cells from one plate for each condition for preparation of protein extracts and Western blot analysis to determine the efficiency of knockdown and the expression of the endogenous protein¹⁵.
    NOTE: With the remaining plates, proceed with cell fixation, using the protocol of choice and subject the samples to immunofluorescence analysis with the antibodies of interest¹⁴.

5. Live Cell Imaging of Mitotic Cells and Data Analysis

1. Perform short-term live cell imaging experiments on mitotic cells with an inverted microscope equipped with a humidified/5%CO₂/thermo-regulated chamber.
   NOTE: In this study, a spinning disk confocal microscope (40X, 0.75 NA) was used, equipped with an EMCCD cooled charge-coupled camera at -50 °C.
2. Prior to acquisition, verify that the chamber has reached the appropriate temperature of 37 °C.
   NOTE: This may take several hours depending on the microscopic system.
3. Place the culture dishes in the microscope chamber 1 hr before acquisition to enable proper equilibrium of the medium and avoid focus drifting due to temperature changes. Monitor the mitotic status of the cells. At this point, 10-15% of the cells should be in the early stages of mitosis (prophase-prometaphase).
4. During the equilibration time, set up the acquisition parameters as determined in prior experiments. Typically, an exposure time for both channels (488 and 594) of .2-3 sec with a laser intensity of 100% and a sensitivity of 121-130 are suitable parameters in our hands.
   NOTE: First tests should be made to determine the minimum laser intensity and acquisition time/interval that result in an appropriate resolution with minimum photobleaching that causes cell damages and perturbs mitotic progression.
5. Choose several fields per condition to obtain a significant number of cells to analyze without exceeding the acquisition interval. Using a spinning disk confocal system, a typical setup will include four different conditions, 7 fields per plate and 2 color channels (488 and 594) with a 1.5-2 min interval over a 75 min-period.
6. Choose cells that are at mitotic entry, re-set the focus once all fields have been chosen and start the acquisition as fast as possible.
7. Monitor the stability of the system for at least three time points and re-set the focus if necessary.
8. After the first short-term live cell imaging of 75 min, new fields of mitotic cells may be chosen to acquire a second set of movies to increase the number of cells being analyzed.
9. Determine well-defined criteria to analyze the mitotic phenotypes of cells, which will depend on the fluorescent markers being used. Defects in mitosis may include prolonged time spent in mitosis (from nuclear breakdown until anaphase), chromosome misalignment, spindle rocking, and cortex blebbing¹⁴.

6. LifeAct-TagGFP2 Adenovirus Transduction in Differentiating C2C12 Mouse Myoblasts

NOTE: The adenofection protocol is also applicable to hard-to-infect mouse C2C12 myoblasts undergoing differentiation.

1. Plate 2 x 10⁵ C2C12 cells in 35 mm culture dishes in growth medium on plastic or on a substrate of choice.
   NOTE: Cell differentiation is improved on gelatine- or matrigel-coated dishes. Plan one additional plate to determine the cell number prior to virus transduction.
2. The following day, cells should have reached 80% of confluency. Induce myoblast differentiation by washing the cells twice with warm PBS and adding 2 ml of differentiation medium (DM).
3. The next day, labeled as day 1 (D1) of differentiation, transduce myocytes with adenovirus LifeAct-TagGFP2 to visualize the actin cytoskeleton in live cells. Count the cell number from the additional plate as described under 3.2. Calculate 5 PFU/cell of LifeAct-TagGFP2 adenovirus and 45 PFU/cell AdLacZ following the example described in Table 1. The total virus quantity is 50 PFU/cell. Viruses were used as described¹⁴
4. Prepare in a sterile hood a 1.5 ml plastic tube for each condition and add 400 μl of warm DM.
5. Thaw an aliquot of the viruses slowly on ice and, if necessary, dilute the virus stock in order to pipet a volume greater than 1 μl to minimize pipetting errors.
6. Add the appropriate amount of virus particles per condition to each 1.5 ml plastic tube containing 400 μl DM and mix gently by pipetting. Place the virus stock immediately back at -80 °C to keep its activity.
7. Aspirate the medium from the dishes and gently pipette the virus mix drop-wise. Incubate the cells at 37 °C, 5% CO₂ and agitate the plates carefully under the sterile hood each 15 min for a total of 1 hr to well cover the cells with the virus.
8. After incubation, gently pipette 1.6 ml DM onto each plate and continue the incubation for an additional 2 hr at 37 °C, 5% CO₂.
9. Meanwhile, prepare an empty transfection mix following the CaPi transfection method. Calculate 200 μl mix for each condition. Use the following example for a total volume of 400 μl mix.
   1. In a 1.5 ml plastic tube, pipette 50 μl 1 M CaCl₂ into 150 μl sterile H₂O and mix by vortexing. After a quick spin, add carefully drop-wise 200 μl HBS2x (280 mM NaCl, 50 mM HEPES, 1.5 mM Na₂HPO₄, pH 7.01-7.05). Gently mix by air injection three times using a 200 μl pipette.
10. Incubate the mix for 30 min at RT. Add slowly drop-wise 200 μl of the transfection mix to each plate and agitate cross-wise. Transfer the plates at 37 °C, 5% CO₂ for 16 hr.
11. The next day, rinse the cells twice with 2 ml warm HEPES (6.7 mM KCl, 150 mM NaCl, 10 mM HEPES, pH 7.3) and add 2 ml DM. Visualize the infection efficiency under an inverted fluorescent microscope at a magnification of 20-40X (air) and acquire three representative images per condition in both fluorescent and transmission channels for documentation.
12. Depending on the desired experiment setup, follow differentiation into myotubes for several days. Cells can be fixed and subsequently subjected to immunofluorescence analysis or live cell imaging studies can be performed.

Results

Transfection of BAG3-GFP plasmid DNA using cationic lipids was associated with heterogeneous expression in HeLa cells, some cells showing barely detectable levels of the protein and others bearing very high BAG3 levels (Figure 2A). In these cells, loss of protein homeostasis was evidenced by accumulation of BAG3-GFP into perinuclear aggregates (Figure 2A, arrows). In contrast, cell transduction with adenoviruses carrying BAG3-GFP exhibited more homogenous...

Discussion

Here, we described a method enabling depletion-rescue experiments to be performed, which is applicable to functional analyses of cell biological processes that are particularly sensitive to overexpression of proteins affecting the stoichiometry and dynamics of protein complexes and macromolecular structures. Mitotic cell division is an extreme example of finely tuned cell morphodynamics that involves the most dramatic and spectacular changes in the overall structure of a cell. Using adenofection combined with commerciall...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
C2C12 Mouse Myoblasts	ATCC	CRL-1772
Adenovirus custom design	Welgen	Custom design
Calcium Chloride	Fisher Scientific	C79-500
CellLight® Actin-GFP, BacMam 2.0	Thermo Fisher	C10582
CellLight® Tubulin-RFP, BacMam 2.0	Thermo Fisher	C10614
Dulbecco’s modified Eagle’s medium (DMEM), High Glucose	Thermo Fisher	11965-092
EDTA	Sigma	E5134
Fetal Bovine Serum (FBS)	Thermo Fisher	12483-020
Fibronectin	Sigma	F1141
Glass bottom dishes, 35 mm	MatTek Corperation	P35G-1.5-20-C Case
HeLa-RFP-H2B	Kind gift of Dr Sabine Elowe, Québec, Canada		Klebig C et al. 2009
HEPES	Fisher Scientific	BP310-1
Horse Serum, New Zealand	Thermo Fisher	16050-122
KCl	Fisher Scientific	BP366-500
L-Glutamine	Thermo Fisher	25030081
Lipofectamine® RNAiMAX Transfection Reagent	Thermo Fisher	13778-150
Minimal Essential Medium (MEM) Alpha	Wisent	310-101-CL
Minimal Essential Medium (MEM) Alpha without Desoxyribonuleosides/Ribonucleosides	Thermo Fisher	12000-022
Minimal Essential Medium (MEM) Alpha without Phenol Red	Thermo Fisher	41061-029
Na2HPO4	Biobasic	S0404
NaCl	Fisher Scientific	BP358-10
OptiMEM	Thermo Fisher	11058-021
rAVCMV-LifeAct-TagGFP2	IBIDI	60121
siRNA duplexes	Dharmacon	Custom design
Thymidine	Sigma	T9250
Trypsine 2.5%	Thermo Fisher	15090-046